231 related articles for article (PubMed ID: 18517072)
1. Predicting outcomes of oral aspirin challenges in patients with asthma, nasal polyps, and chronic sinusitis.
Dursun AB; Woessner KA; Simon RA; Karasoy D; Stevenson DD
Ann Allergy Asthma Immunol; 2008 May; 100(5):420-5. PubMed ID: 18517072
[TBL] [Abstract][Full Text] [Related]
2. The blocking effect of essential controller medications during aspirin challenges in patients with aspirin-exacerbated respiratory disease.
White AA; Stevenson DD; Simon RA
Ann Allergy Asthma Immunol; 2005 Oct; 95(4):330-5. PubMed ID: 16279562
[TBL] [Abstract][Full Text] [Related]
3. The relationship between historical aspirin-induced asthma and severity of asthma induced during oral aspirin challenges.
Williams AN; Simon RA; Woessner KM; Stevenson DD
J Allergy Clin Immunol; 2007 Aug; 120(2):273-7. PubMed ID: 17481713
[TBL] [Abstract][Full Text] [Related]
4. The natural history and clinical characteristics of aspirin-exacerbated respiratory disease.
Berges-Gimeno MP; Simon RA; Stevenson DD
Ann Allergy Asthma Immunol; 2002 Nov; 89(5):474-8. PubMed ID: 12452205
[TBL] [Abstract][Full Text] [Related]
5. Failure of tacrolimus to prevent aspirin-induced respiratory reactions in patients with aspirin-exacerbated respiratory disease.
Stevenson DD; Mehra PK; White AA; Gupta S; Woessner KM; Simon RA
J Allergy Clin Immunol; 2005 Oct; 116(4):755-60. PubMed ID: 16210047
[TBL] [Abstract][Full Text] [Related]
6. Improvements in an oral aspirin challenge protocol for the diagnosis of aspirin hypersensitivity.
Cormican LJ; Farooque S; Altmann DR; Lee TH
Clin Exp Allergy; 2005 Jun; 35(6):717-22. PubMed ID: 15969660
[TBL] [Abstract][Full Text] [Related]
7. Rational approach to aspirin dosing during oral challenges and desensitization of patients with aspirin-exacerbated respiratory disease.
Hope AP; Woessner KA; Simon RA; Stevenson DD
J Allergy Clin Immunol; 2009 Feb; 123(2):406-10. PubMed ID: 19056109
[TBL] [Abstract][Full Text] [Related]
8. Safety of high-dose rofecoxib in patients with aspirin-exacerbated respiratory disease.
Woessner KM; Simon RA; Stevenson DD
Ann Allergy Asthma Immunol; 2004 Oct; 93(4):339-44. PubMed ID: 15521369
[TBL] [Abstract][Full Text] [Related]
9. Aspirin sensitivity and severity of asthma: evidence for irreversible airway obstruction in patients with severe or difficult-to-treat asthma.
Mascia K; Haselkorn T; Deniz YM; Miller DP; Bleecker ER; Borish L;
J Allergy Clin Immunol; 2005 Nov; 116(5):970-5. PubMed ID: 16275362
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for acetaminophen and nimesulide intolerance in patients with NSAID-induced skin disorders.
Asero R
Ann Allergy Asthma Immunol; 1999 Jun; 82(6):554-8. PubMed ID: 10400483
[TBL] [Abstract][Full Text] [Related]
11. Certain subphenotypes of aspirin-exacerbated respiratory disease distinguished by latent class analysis.
Bochenek G; Kuschill-Dziurda J; Szafraniec K; Plutecka H; Szczeklik A; Nizankowska-Mogilnicka E
J Allergy Clin Immunol; 2014 Jan; 133(1):98-103.e1-6. PubMed ID: 23993879
[TBL] [Abstract][Full Text] [Related]
12. Role of aspirin desensitization in the management of chronic rhinosinusitis.
Rizk H
Curr Opin Otolaryngol Head Neck Surg; 2011 Jun; 19(3):210-7. PubMed ID: 21372715
[TBL] [Abstract][Full Text] [Related]
13. Safety of triflusal (antiplatelet drug) in patients with aspirin-exacerbated respiratory diseases.
Fraj J; Valero A; Vives R; Pérez I; Borja J; Izquierdo I; Picado C
Allergy; 2008 Jan; 63(1):112-5. PubMed ID: 18053020
[TBL] [Abstract][Full Text] [Related]
14. Sensitivity to nonsteroidal anti-inflammatory drugs.
Namazy JA; Simon RA
Ann Allergy Asthma Immunol; 2002 Dec; 89(6):542-50; quiz 550, 605. PubMed ID: 12487218
[TBL] [Abstract][Full Text] [Related]
15. Long-term asthma outcomes after endoscopic sinus surgery in aspirin triad patients.
Loehrl TA; Ferre RM; Toohill RJ; Smith TL
Am J Otolaryngol; 2006; 27(3):154-60. PubMed ID: 16647978
[TBL] [Abstract][Full Text] [Related]
16. Gene-expression signatures of nasal polyps associated with chronic rhinosinusitis and aspirin-sensitive asthma.
Platt M; Metson R; Stankovic K
Curr Opin Allergy Clin Immunol; 2009 Feb; 9(1):23-8. PubMed ID: 19532090
[TBL] [Abstract][Full Text] [Related]
17. Desensitization to aspirin in aspirin-sensitive patients with rhino-sinusitis and asthma: a review.
Knight A
J Otolaryngol; 1989 Jun; 18(4):165-7. PubMed ID: 2661852
[TBL] [Abstract][Full Text] [Related]
18. Incidence of medico-surgical treatment for nasal polyps on the development of associated asthma.
Jankowski R; Moneret-Vautrin DA; Goetz R; Wayoff M
Rhinology; 1992 Dec; 30(4):249-58. PubMed ID: 1470826
[TBL] [Abstract][Full Text] [Related]
19. Lack of cross-reactivity between rofecoxib and aspirin in aspirin-sensitive patients with asthma.
Stevenson DD; Simon RA
J Allergy Clin Immunol; 2001 Jul; 108(1):47-51. PubMed ID: 11447381
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of aspirin-exacerbated respiratory disease in patients with asthma in Turkey: a cross-sectional survey.
Bavbek S; Yilmaz I; Celik G; Aydin O; Erkekol FÖ; Orman A; Kurt E; Ediger D; Dursun B; Abadoğlu O; Ozşeker F; Akkaya E; Karakiş GP; Canbakan S; Yüksel S; Misirligil Z
Allergol Immunopathol (Madr); 2012; 40(4):225-30. PubMed ID: 21889254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]